{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:47:40Z","timestamp":1787964460349,"version":"build-2784847793"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008276","name":"College of Medicine, University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Hereditary transthyretin amyloidosis (hATTR) can cause multisystem organ disorders including polyneuropathy and cardiomyopathy. Amongst the many known pathologic mutations of the transthyretin (<jats:italic>TTR<\/jats:italic>) gene, the Val122Ile (V122I) mutation can be found in 3\u20134% of African Americans. Up to 47% of patients with the V122I hATTR cardiomyopathy had a history of carpal tunnel syndrome (CTS). This raises the question should we screen for this mutation in African Americans with bilateral CTS for the purpose of preventing advanced disease associated with hATTR. This is a prospective pilot study to determine the likelihood of African Americans with bilateral CTS having the V122I mutation and whether various clinical factors contribute to that probability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>Adult African American patients without prior history of amyloidosis diagnosed with bilateral CTS were recruited for the study. They received genetic testing to screen for a <jats:italic>TTR<\/jats:italic> mutation. They also completed questionnaires to screen for symptoms of cardiomyopathy and neuropathy, other risk factors for CTS, and family history of CTS and cardiomyopathy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>Two of the sixteen patients (12.5%) in this cohort were found to have the V122I mutation. The absence of polyneuropathy and cardiomyopathy symptoms, presence of other CTS risk factors, and absence of family history of CTS and cardiomyopathy did not decrease the likelihood of V122I mutation in this cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The frequency of V122I transthyretin mutation in African Americans with bilateral CTS may be higher than 3\u20134%. The presence of bilateral CTS alone may be a justification to screen for <jats:italic>TTR<\/jats:italic> mutation in this population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.949401","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T07:06:39Z","timestamp":1658819199000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["The Frequency of V122I Transthyretin Mutation in a Cohort of African American Individuals With Bilateral Carpal Tunnel Syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Jeffrey Z.","family":"Shije","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A. B.","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Smotherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease","volume":"15","author":"Adams","year":"2019","journal-title":"Nat Rev Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/13506129.2015.1051219","article-title":"Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African\u2013Americans","volume":"22","author":"Jacobson","year":"2015","journal-title":"Amyloid."},{"key":"B4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s004390050199","article-title":"Revised transthyretin Ile 122 allele frequency in African-Americans","volume":"98","author":"Jacobson","year":"1996","journal-title":"Hum Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/13506120500107162","article-title":"A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population","volume":"12","author":"Yamashita","year":"2005","journal-title":"Amyloid."},{"key":"B6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ahj.2009.08.006","article-title":"Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis","volume":"158","author":"Connors","year":"2009","journal-title":"Am Heart J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jns.12153","article-title":"\u201cRed-flag\u201d symptom clusters in transthyretin familial amyloid polyneuropathy","volume":"21","author":"Concei\u00e7\u00e3o","year":"2016","journal-title":"J Peripher Nerv Syst."},{"key":"B8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jacc.2019.04.055","article-title":"Carpal Tunnel Syndrome and Future Amyloidosis","volume":"74","author":"Ton","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1056\/NEJMe1805499","article-title":"Oligonucleotide drugs for transthyretin amyloidosis","volume":"379","author":"Buxbaum","year":"2018","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.2105\/AJPH.88.10.1447","article-title":"Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies","volume":"88","author":"Rempel","year":"1998","journal-title":"Am J Public Health."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/mus.880161220","article-title":"Literature review of the usefulness of nerve conduction studies and electromyography for the evaluation of patients with carpal tunnel syndrome. AAEM Quality Assurance Committee","volume":"16","author":"Jablecki","year":"1993","journal-title":"Muscle Nerve."},{"key":"B13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ejhf.1742","article-title":"Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies","volume":"22","author":"Milandri","year":"2020","journal-title":"Eur J Heart Fail."},{"key":"B14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/annweh\/wxy015","article-title":"Observed differences between males and females in surgically treated carpal tunnel syndrome among non-manual workers: a sensitivity analysis of findings from a large population study","volume":"62","author":"Farioli","year":"2018","journal-title":"Ann Work Expo Health."},{"key":"B15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1006\/enrs.2000.4042","article-title":"Male and female rate differences in carpal tunnel syndrome injuries: personal attributes or job tasks?","volume":"83","author":"McDiarmid","year":"2000","journal-title":"Environ Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00415-020-10127-8","article-title":"Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers","volume":"268","author":"Salvalaggio","year":"2021","journal-title":"J Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jacc.2019.04.054","article-title":"Association of carpal tunnel syndrome with amyloidosis, heart failure, and adverse cardiovascular outcomes","volume":"74","author":"Fosbol","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release","volume":"72","author":"Sperry","year":"2018","journal-title":"J Am Coll Cardiol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.949401\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T07:06:42Z","timestamp":1658819202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.949401\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":18,"alternative-id":["10.3389\/fneur.2022.949401"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.949401","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"article-number":"949401"}}